The Royal Prince Alfred Hospital is a major public teaching hospital in Sydney, Australia, located on Missenden Road in Camperdown.

There are 911 beds in Royal Prince Alfred Hospital.

During the past decade, Royal Prince Alfred Hospital conducted 196 clinical trials. In the 10-year time frame, 196 clinical trials started and 79 clinical trials were completed, i.e. on average, 40.3% percent of trials that started reached the finish line to date. In the past 5 years, 100 clinical trials started and 50 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Prince Alfred Hospital" #1 sponsor was "Celgene" with 15 trials, followed by "Gilead Sciences" with 14 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 13 trials sponsored, "Pfizer" with 13 trials sponsored and "Trans Tasman Radiation Oncology Group" with 13 trials sponsored. Other sponsors include 263 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Prince Alfred Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 23 trials as a collaborator, "University of Sydney" with 11 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 7 trials as a collaborator, "Monash University" with 7 trials as a collaborator and "Royal Prince Alfred Hospital, Sydney, Australia" with 7 trials as a collaborator. Other collaborators include 323 different institutions and companies that were collaborators in the rest 258 trials.

According to Clinical.Site data, the most researched conditions in "Royal Prince Alfred Hospital" are "Multiple Myeloma" (14 trials), "Idiopathic Pulmonary Fibrosis" (10 trials), "Hemophilia A" (8 trials), "Heart Failure" (6 trials) and "Hemophilia B" (6 trials). Many other conditions were trialed in "Royal Prince Alfred Hospital" in a lesser frequency.

Most popular intervention types in "Royal Prince Alfred Hospital" are "Drug" (231 trials), "Other" (43 trials), "Device" (27 trials), "Biological" (25 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (79 trials), "Dexamethasone" (9 trials), "Bortezomib" (6 trials), "Radiotherapy" (6 trials) and "Azacitidine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Royal Prince Alfred Hospital" are 307 trials for "All" genders, 16 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 115 active trials in "Royal Prince Alfred Hospital". 5 are not yet recruiting, 59 are recruiting, 46 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 163 completed trials in Royal Prince Alfred Hospital, 1 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Prince Alfred Hospital, 19 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 153 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 50 trials that are defined as “Not Applicable".